Font Size: a A A
Keyword [Newly diagnosed]
Result: 41 - 60 | Page: 3 of 10
41. Curative Effects Observation Of Continuous Subcutaneous Insulin Infusion And Multisubcutaneous Insulin Injection In Newly Diagnosed Type 2 Diabetic Patients
42. Study On The Change Of Chemerin Expression In 3T3-L1 Preadipocyte Differentiation And The Plasma Chemerin Levels In Newly Diagnosed Patients With Type 2 Diabetes Mellitus
43. The Level Of Fasting Serum Apelin And The Relationship Of Fasting Serum Apelin And Other Factors In Newly Diagnosed Type 2 Diabetes Patients
44. Expression And Significance Of Beta-catenin And CyclinD1 In Newly Diagnosed Acute Myeloid Leukemia Patients
45. Advanced Glycation Index And Atherosclerosis In Newly Diagnosed Type 2 Diabetes
46. Study Of The Relationship Between Serum Total Bilirubin And Subclinical Atherosclerosis In Newly Diagnosed Type 2 Diabetes Patients
47. Effects Of Intensive Insulin Therapy On Function Of Pancreatic β Cell In Type 2 Diabetes At Different Phages
48. The Influencing Factors Of The Vascular Endothelial Injury In Newly Diagnosed Type 2 Diabetes And The Effect Of Transient Continuous Subcutaneous Insulin Infusion Therapy
49. Effect Of Short-term CSâ…¡ Intensive Therapy On The Level Of GLP-1 In Newly Diagnosed Type 2 Diabetes
50. Metformin In Therapy For Patients With Newly Diagnosed Type 2 Diabetes And Impaired Glucose Tolerance
51. The Evaluation Of Body Iron Metabolism In Pre Diabetes And Newly-diagnosed Type 2 Diabetes And The Role In The Pathogenesis
52. The Incidence Of Artery Atheromatous Plaques In Newly Diagnosed Type 2 Diabetic Patients And The Correlative Risk Factors
53. Efficacy And Safety Of Standard Or Topiramate For Monotherapy In Patients With Newly Diagnosed Epilepsy
54. The Effects Of Short-Term Intensive Insulin Therapy On HPA Axis Function In Newly-Diagnosed Type 2 Diabetic Patients
55. Effects Of Decoction-Combined CSII Treatment On Patients With Newly Diagnosed Type 2 Diabetes Mellitus (Vital Qi And Yin Deficiency Syndrome)
56. Levels Of Serum Pancreatic-derived Factor (PANDER) And Their Correlation With Islet β Cell Function In The Newly Diagnosed Type 2 Diabetes
57. The Effect Of Repaglinide On β-cell Function Of Newly Diagnosed Type 2 Diabetes Mellitus Evaluated By True Insulin
58. The Expression Of CD4~+ CD25~+ Foxp3~+ Treg In Newly Diagnosed Type 2 Diabetic Patients
59. Islet β-cell Function And It's Relation To Amylin And Melatonin In Newly Diagnosed Elderly Diabetic Patients
60. Relationship Between Plasma Omentin-1, Visfatin And Atherosclerosis In Newly Diagnosed Type 2 Diabetes Patients
  <<First  <Prev  Next>  Last>>  Jump to